UBS Lux Equity Fund Biotech USD vs SEB Bioteknikfond D

UBS Lux Equity Fund Biotech USD vs SEB Bioteknikfond D

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    5

2. SEB Bioteknikfond D

  • Security

    SEB Bioteknikfond D EUR Lux Utd

  • Fee

    1.69%

  • ISIN

    LU0118405827

  • Holdings

    24

Fund Holdings

We have information about 7 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66). In comparison with SEB Bioteknikfond D, we have 24 holdings where Gilead Sciences is the largest holding (10.04), followed by Vertex (8.8) and Amgen (8.54).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and SEB Bioteknikfond D.

UBS Lux Equity Fund Biotech USD SEB Bioteknikfond D
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Gilead Sciences Inc
USA
10.04 %
2. Moderna Inc
9.21 %
2. Vertex Pharmaceuticals Inc
8.8 %
3. Gilead Sciences Inc
USA
4.66 %
3. Amgen Inc
USA
8.54 %
4. BioNTech SE
4.13 %
4. Regeneron Pharmaceuticals Inc
5.09 %
5. Karuna Therapeutics Inc
3.75 %
5. Alnylam Pharmaceuticals Inc
5.07 %
- 6. AstraZeneca ADR
Sweden UK
4.49 %
- 7. Verona Pharma ADR
3.46 %
- 8. Argenx ADR
2.72 %
- 9. Illumina Inc
2.72 %
- 10. BioNTech SE
2.41 %
- 11. Madrigal Pharmaceuticals Inc
1.88 %
- 12. BoneSupport AB
Sweden
1.82 %
- 13. BioMarin Pharmaceutical Inc
1.7 %
- 14. Krystal Biotech Inc
1.48 %
- 15. NewAmsterdam Pharma NV
1.46 %
- 16. BridgeBio Pharma Inc
1.45 %
- 17. Cytokinetics Inc
1.4 %
- 18. Ionis Pharmaceuticals Inc
1.37 %
- 19. Xenon Pharmaceuticals
1.37 %
- 20. Insmed Inc
1.32 %
- 21. Onward Medical NV
1.31 %
- 22. Janux Therapeutics Inc
1.3 %
- 23. Structure Therapeutics ADR
1.24 %
- 24. Kymera Therapeutics Inc
1.09 %

The list of fund holdings was last updated on September 10, 2025.